These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9684758)

  • 41. von Willebrand factor can substitute for plasma fibrinogen in ADP-induced platelet aggregation.
    Timmons S; Hawiger J
    Trans Assoc Am Physicians; 1986; 99():226-35. PubMed ID: 3496699
    [No Abstract]   [Full Text] [Related]  

  • 42. Platelet aggregation, haematocrit, and fibrinogen.
    Lowe GD; Forbes CD
    Lancet; 1985 Feb; 1(8425):395-6. PubMed ID: 2857445
    [No Abstract]   [Full Text] [Related]  

  • 43. Contribution of von Willebrand factor to thrombus formation on neointima of rabbit stenotic iliac artery under high blood-flow velocity.
    Yamashita A; Asada Y; Sugimura H; Yamamoto H; Marutsuka K; Hatakeyama K; Tamura S; Ikeda Y; Sumiyoshi A
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1105-10. PubMed ID: 12750116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The significance of thrombosis after experimental pulmonary thromboembolism].
    Ji Y; Guan H; Gu L
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Dec; 24(12):718-21. PubMed ID: 11930698
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of the low molecular weight heparin/non steroidal anti-inflammatory drugs association on an experimental thrombosis induced by laser.
    Doutremepuich F; Aguejouf O; Imbault P; Oualane FA; Doutremepuich C
    Thromb Res; 1995 Feb; 77(4):311-9. PubMed ID: 7740522
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of plasma fibrinogen concentration on the inhibition of platelet aggregation after ticlopidine compared with aspirin.
    Tohgi H; Takahashi H; Kashiwaya M; Watanabe K
    Stroke; 1994 Oct; 25(10):2017-21. PubMed ID: 8091447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of fibrinogen in aggregation of platelets in burn injury.
    Levin GY; Egorihina MN
    Burns; 2010 Sep; 36(6):806-10. PubMed ID: 20236770
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of adenosine 5'-diphosphate (ADP)- and collagen-induced platelet aggregation in canine leishmaniasis.
    Pelagalli A; Ciaramella P; Lombardi P; Pero ME; Cortese L; Corona M; Oliva G; Avallone L
    J Comp Pathol; 2004; 130(2-3):124-9. PubMed ID: 15003469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dietary fatty acids and arterial thrombosis: effects and mechanism of action with special reference to linoleic acid.
    Hornstra G
    Adv Exp Med Biol; 1977; 82():545-51. PubMed ID: 920413
    [No Abstract]   [Full Text] [Related]  

  • 50. [Fibrinogen: a risk factor].
    Potron G; N'Guyen P; Pignon B
    J Mal Vasc; 1996; 21(3):126-32. PubMed ID: 8965039
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extract of Ulmus macrocarpa Hance prevents thrombus formation through antiplatelet activity.
    Yang WK; Lee JJ; Sung YY; Kim DS; Myung CS; Kim HK
    Mol Med Rep; 2013 Sep; 8(3):726-30. PubMed ID: 23846328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ADP induced blood platelet activation: a review.
    Gachet C; Cazenave JP
    Nouv Rev Fr Hematol (1978); 1991; 33(5):347-58. PubMed ID: 1803325
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thrombocytopathy leading to impaired in vivo haemostasis and thrombosis in platelet type von Willebrand disease.
    Kaur H; Corscadden K; Ware J; Othman M
    Thromb Haemost; 2017 Feb; 117(3):543-555. PubMed ID: 28004055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition by D-MePhe-Pro-Arg-H (GYKI-14766) of thrombus growth in experimental models of thrombosis.
    Bagdy D; Szabó G; Barabás E; Bajusz S
    Thromb Haemost; 1992 Aug; 68(2):125-9. PubMed ID: 1412156
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of physiological levels of fibrinogen on platelet aggregation.
    Meade TW; Vickers MV; Thompson SG; Seghatchian MJ
    Thromb Res; 1985 Jun; 38(5):527-34. PubMed ID: 4012675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelet kinetics--1975.
    Ries CA
    Ser Haematol; 1975; 8(3):98-104. PubMed ID: 1234386
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibitors of platelet function in the prevention of arterial thrombosis.
    Harker LA
    Ser Haematol; 1975; 8(3):105-24. PubMed ID: 790583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of arterial thrombosis and platelet function by nafazatrom.
    Buchanan MR; Blajchman M; Hirsh J
    Thromb Res; 1982 Oct; 28(2):157-70. PubMed ID: 6758186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects on platelet aggregation of oral prostaglandin E2 used for the induction of labour.
    Myatt L; Elder MG
    Br J Obstet Gynaecol; 1975 Jun; 82(6):449-52. PubMed ID: 1138835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.